BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33794628)

  • 1. [Pathologic tumor volume predicting survival outcomes of patients with local advanced glottic carcinoma].
    Gong H; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Zhou J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Apr; 35(4):316-320. PubMed ID: 33794628
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathologic Tumor Size as a Predictor of the Survival Outcomes of Patients With Glottic Carcinoma.
    Gong H; Zhou L; Wu H; Tao L; Zhang M; Chen X; Li X; Li C; Zhou J; Wang S
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):353-358. PubMed ID: 32633609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of tumor volume in supraglottic and glottic laryngeal carcinoma.
    van Bockel LW; Monninkhof EM; Pameijer FA; Terhaard CH
    Strahlenther Onkol; 2013 Dec; 189(12):1009-14. PubMed ID: 24196282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative tracheotomy as reflection of tumor size impacting oncologic outcomes of patients with advanced stage glottic carcinoma.
    Gong H; Zhou L; Wu C; Hsueh CY; Tao L; Wu H; Zhang M; Chen X; Li C; Zhou J
    Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):4943-4950. PubMed ID: 33675419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of pathological carcinoma size in patients with T2 glottic laryngeal squamous cell carcinoma.
    Zhou J; Zhu X; Yang Y; Zhou L; Gong H; Xu C; Tao L
    Acta Otolaryngol; 2023 Apr; 143(4):317-321. PubMed ID: 36994848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of pathological tumor size in patients with supraglottic carcinoma.
    Gong H; Zhou L; Hsueh CY; Wu H; Tao L; Zhang M; Chen X; Li C; Mo M; Zhou J
    Am J Otolaryngol; 2021; 42(1):102757. PubMed ID: 33128995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Primary Tumor Volume With Survival in Patients With T3 Glottic Cancer Treated With Radiotherapy: A Study of the Canadian Head & Neck Collaborative Research Initiative.
    Malik NH; Fu R; Hainc N; Noel CW; de Almeida JR; Hosni A; Hui Huang S; Yu E; Dzioba A; Leung A; Mangat A; MacNeil D; Nichols AC; Hiremath SB; Chakraborty S; Jooya A; Gaudet M; Johnson-Obaseki S; Whelan J; Forghani R; Hier MP; Morand G; Sultanem K; Dort J; Lysack J; Matthews W; Nakoneshny S; Gill G; Globerman A; Kerr P; Maralani P; Karam I; Eskander A
    JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):103-109. PubMed ID: 36480193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of pRB predicts disease relapse in early glottic cancer treated with transoral laser microsurgery.
    Lee LA; Fang TJ; Li HY; Huang CG; Chen TC; Liao CT; Kang CJ; Chang KP; Yen TC
    Laryngoscope; 2019 Jun; 129(6):E220-E226. PubMed ID: 30382590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor volume as a prognostic factor of locally advanced laryngeal cancer.
    de Andrade NMM; Dedivitis RA; Ramos DM; Matos LL; Garcia MRT; Conti GG; Kowalski LP
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1627-1635. PubMed ID: 33095433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of pathologically determined tumour volume in glottic carcinomas treated by transoral laser microsurgery.
    Wilkie MD; Lightbody KA; Pinto R; Tandon S; Jones TM; Lancaster J
    Clin Otolaryngol; 2015 Dec; 40(6):610-5. PubMed ID: 25816841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of MRI-based late-course tumor volume in locoregionally advanced nasopharyngeal carcinoma.
    Yan G; Feng Y; Wu M; Li C; Wei Y; Hua L; Zhao G; Hu Z; Yao S; Hou L; Chen X; Liu Q; Huang Q
    Radiat Oncol; 2022 Jun; 17(1):111. PubMed ID: 35761414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer.
    Chung SY; Kim KH; Keum KC; Koh YW; Kim SH; Choi EC; Lee CG
    Cancer Res Treat; 2018 Jan; 50(1):156-163. PubMed ID: 28301924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of therapeutic effect and prognostic factors on early glottic carcinoma.
    Peng Z; Li Y; Jin L; Tao X; Cai X; Feng J; Liu R; Zhang Q; Li L
    Photodiagnosis Photodyn Ther; 2016 Sep; 15():167-71. PubMed ID: 27378675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma.
    Zvrko E; Mikic A; Vuckovic L
    Auris Nasus Larynx; 2010 Feb; 37(1):77-83. PubMed ID: 19553039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early glottic cancer involving the anterior commissure treated by transoral laser cordectomy.
    Hoffmann C; Cornu N; Hans S; Sadoughi B; Badoual C; Brasnu D
    Laryngoscope; 2016 Aug; 126(8):1817-22. PubMed ID: 26597482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcomes of supracricoid partial laryngectomy with cricohyoidoepiglottopexy for glottic carcinoma.
    Gong H; Zhou L; Wu H; Tao L; Chen X; Li X; Li C; Zhou J
    Acta Otolaryngol; 2019 Sep; 139(9):803-809. PubMed ID: 31240973
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
    Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of total tumor volume in advanced-stage laryngeal and hypopharyngeal carcinoma.
    Yang CJ; Kim DY; Lee JH; Roh JL; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2013 Dec; 108(8):509-15. PubMed ID: 24590673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.
    Ko HC; Harari PM; Chen S; Wieland AM; Yu M; Baschnagel AM; Kimple RJ; Witek ME
    JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1126-1133. PubMed ID: 29049434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.